4.6 Review

Collaborative Care to Improve the Management of Depressive Disorders A Community Guide Systematic Review and Meta-Analysis

Journal

AMERICAN JOURNAL OF PREVENTIVE MEDICINE
Volume 42, Issue 5, Pages 525-538

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2012.01.019

Keywords

-

Funding

  1. Pfizer Pharmaceuticals

Ask authors/readers for more resources

Context: To improve the quality of depression management, collaborative care models have been developed from the Chronic Care Model over the past 20 years. Collaborative care is a multicomponent, healthcare system-level intervention that uses case managers to link primary care providers, patients, and mental health specialists. In addition to case management support, primary care providers receive consultation and decision support from mental health specialists (i.e., psychiatrists and psychologists). This collaboration is designed to (1) improve routine screening and diagnosis of depressive disorders; (2) increase provider use of evidence-based protocols for the proactive management of diagnosed depressive disorders; and (3) improve clinical and community support for active client/patient engagement in treatment goal-setting and self-management. Evidence acquisition: A team of subject matter experts in mental health, representing various agencies and institutions, conceptualized and conducted a systematic review and meta-analysis on collaborative care for improving the management of depressive disorders. This team worked under the guidance of the Community Preventive Services Task Force, a nonfederal, independent, volunteer body of public health and prevention experts. Community Guide systematic review methods were used to identify, evaluate, and analyze available evidence. Evidence synthesis: An earlier systematic review with 37 RCTs of collaborative care studies published through 2004 found evidence of effectiveness of these models in improving depression outcomes. An additional 32 studies of collaborative care models conducted between 2004 and 2009 were found for this current review and analyzed. The results from the meta-analyses suggest robust evidence of effectiveness of collaborative care in improving depression symptoms (standardized mean difference [SMD] = 0.34); adherence to treatment (OR = 2.22); response to treatment (OR = 1.78); remission of symptoms (OR = 1.74); recovery from symptoms (OR = 1.75); quality of life/functional status (SMD = 0.12); and satisfaction with care (SMD = 0.39) for patients diagnosed with depression (all effect estimates were significant). Conclusions: Collaborative care models are effective in achieving clinically meaningful improvements in depression outcomes and public health benefits in a wide range of populations, settings, and organizations. Collaborative care interventions provide a supportive network of professionals and peers for patients with depression, especially at the primary care level. (Am J Prev Med 2012;42(5):525-538) Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available